311 related articles for article (PubMed ID: 27206446)
1. Enhanced oral bioavailability of glycyrrhetinic acid via nanocrystal formulation.
Lei Y; Kong Y; Sui H; Feng J; Zhu R; Wang W
Drug Deliv Transl Res; 2016 Oct; 6(5):519-25. PubMed ID: 27206446
[TBL] [Abstract][Full Text] [Related]
2. Improved oral bioavailability for lutein by nanocrystal technology: formulation development, in vitro and in vivo evaluation.
Chang D; Ma Y; Cao G; Wang J; Zhang X; Feng J; Wang W
Artif Cells Nanomed Biotechnol; 2018 Aug; 46(5):1018-1024. PubMed ID: 28749189
[TBL] [Abstract][Full Text] [Related]
3. Development of surface stabilized candesartan cilexetil nanocrystals with enhanced dissolution rate, permeation rate across CaCo-2, and oral bioavailability.
Jain S; Reddy VA; Arora S; Patel K
Drug Deliv Transl Res; 2016 Oct; 6(5):498-510. PubMed ID: 27129488
[TBL] [Abstract][Full Text] [Related]
4. Characterization and evaluation in vivo of baicalin-nanocrystals prepared by an ultrasonic-homogenization-fluid bed drying method.
Shi-Ying J; Jin H; Shi-Xiao J; Qing-Yuan L; Jin-Xia B; Chen HG; Rui-Sheng L; Wei W; Hai-Long Y
Chin J Nat Med; 2014 Jan; 12(1):71-80. PubMed ID: 24484600
[TBL] [Abstract][Full Text] [Related]
5. Preparation and Evaluation of Diosgenin Nanocrystals to Improve Oral Bioavailability.
Liu CZ; Chang JH; Zhang L; Xue HF; Liu XG; Liu P; Fu Q
AAPS PharmSciTech; 2017 Aug; 18(6):2067-2076. PubMed ID: 27995466
[TBL] [Abstract][Full Text] [Related]
6. Formulation, optimization, and in vitro-in vivo evaluation of olmesartan medoxomil nanocrystals.
Jain S; Patel K; Arora S; Reddy VA; Dora CP
Drug Deliv Transl Res; 2017 Apr; 7(2):292-303. PubMed ID: 28116656
[TBL] [Abstract][Full Text] [Related]
7. Enhanced dissolution rate and oral bioavailability of simvastatin nanocrystal prepared by sonoprecipitation.
Jiang T; Han N; Zhao B; Xie Y; Wang S
Drug Dev Ind Pharm; 2012 Oct; 38(10):1230-9. PubMed ID: 22229827
[TBL] [Abstract][Full Text] [Related]
8. Eplerenone nanocrystals engineered by controlled crystallization for enhanced oral bioavailability.
Khan MA; Ansari MM; Arif ST; Raza A; Choi HI; Lim CW; Noh HY; Noh JS; Akram S; Nawaz HA; Ammad M; Alamro AA; Alghamdi AA; Kim JK; Zeb A
Drug Deliv; 2021 Dec; 28(1):2510-2524. PubMed ID: 34842018
[TBL] [Abstract][Full Text] [Related]
9. Formulation strategy and evaluation of nanocrystal piroxicam orally disintegrating tablets manufacturing by freeze-drying.
Lai F; Pini E; Corrias F; Perricci J; Manconi M; Fadda AM; Sinico C
Int J Pharm; 2014 Jun; 467(1-2):27-33. PubMed ID: 24680963
[TBL] [Abstract][Full Text] [Related]
10. Bexarotene nanocrystal-Oral and parenteral formulation development, characterization and pharmacokinetic evaluation.
Chen L; Wang Y; Zhang J; Hao L; Guo H; Lou H; Zhang D
Eur J Pharm Biopharm; 2014 May; 87(1):160-9. PubMed ID: 24333772
[TBL] [Abstract][Full Text] [Related]
11. Enhanced bioavailability after oral and pulmonary administration of baicalein nanocrystal.
Zhang J; Lv H; Jiang K; Gao Y
Int J Pharm; 2011 Nov; 420(1):180-8. PubMed ID: 21878378
[TBL] [Abstract][Full Text] [Related]
12. Ursolic Acid Nanocrystals for Dissolution Rate and Bioavailability Enhancement: Influence of Different Particle Size.
Pi J; Liu Z; Wang H; Gu X; Wang S; Zhang B; Luan H; Zhu Z
Curr Drug Deliv; 2016; 13(8):1358-1366. PubMed ID: 26953239
[TBL] [Abstract][Full Text] [Related]
13. Nanocrystal-based per-oral itraconazole delivery: superior in vitro dissolution enhancement versus Sporanox® is not realized in in vivo drug absorption.
Sarnes A; Kovalainen M; Häkkinen MR; Laaksonen T; Laru J; Kiesvaara J; Ilkka J; Oksala O; Rönkkö S; Järvinen K; Hirvonen J; Peltonen L
J Control Release; 2014 Apr; 180():109-16. PubMed ID: 24566254
[TBL] [Abstract][Full Text] [Related]
14. Formulation of 20(S)-protopanaxadiol nanocrystals to improve oral bioavailability and brain delivery.
Chen C; Wang L; Cao F; Miao X; Chen T; Chang Q; Zheng Y
Int J Pharm; 2016 Jan; 497(1-2):239-47. PubMed ID: 26680316
[TBL] [Abstract][Full Text] [Related]
15. Cefdinir nanosuspension for improved oral bioavailability by media milling technique: formulation, characterization and in vitro-in vivo evaluations.
Sawant KK; Patel MH; Patel K
Drug Dev Ind Pharm; 2016; 42(5):758-68. PubMed ID: 26548349
[TBL] [Abstract][Full Text] [Related]
16. Development and Characterization of Venetoclax Nanocrystals for Oral Bioavailability Enhancement.
Kala SG; Chinni S
AAPS PharmSciTech; 2021 Mar; 22(3):92. PubMed ID: 33683477
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of cellular uptake, transport and oral absorption of protease inhibitor saquinavir by nanocrystal formulation.
He Y; Xia DN; Li QX; Tao JS; Gan Y; Wang C
Acta Pharmacol Sin; 2015 Sep; 36(9):1151-60. PubMed ID: 26256404
[TBL] [Abstract][Full Text] [Related]
18. Preparation of apigenin nanocrystals using supercritical antisolvent process for dissolution and bioavailability enhancement.
Zhang J; Huang Y; Liu D; Gao Y; Qian S
Eur J Pharm Sci; 2013 Mar; 48(4-5):740-7. PubMed ID: 23305994
[TBL] [Abstract][Full Text] [Related]
19. Fabrication of carvedilol nanosuspensions through the anti-solvent precipitation-ultrasonication method for the improvement of dissolution rate and oral bioavailability.
Liu D; Xu H; Tian B; Yuan K; Pan H; Ma S; Yang X; Pan W
AAPS PharmSciTech; 2012 Mar; 13(1):295-304. PubMed ID: 22246736
[TBL] [Abstract][Full Text] [Related]
20. Development of posaconazole nanocrystalline solid dispersion: preparation, characterization and
Rayapolu RG; Yadav B; Apte SS; Venuganti VVK
Pharm Dev Technol; 2024 Jun; 29(5):530-540. PubMed ID: 38713634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]